scholarly journals The incidence of atypical patterns ofBCR-ABL1rearrangement and molecular-cytogenetic response to tyrosine kinase inhibitor therapy in newly diagnosed cases with chronic myeloid leukemia (CML)

2018 ◽  
Vol 53 (2) ◽  
pp. 152
Author(s):  
Željka Tkalčić Švabek ◽  
Marina Josipović ◽  
Ivana Horvat ◽  
Renata Zadro ◽  
Sanja Davidović-Mrsić
Keyword(s):  
Chronic Myeloid Leukemia ◽  
Tyrosine Kinase ◽  
Tyrosine Kinase Inhibitor ◽  
Myeloid Leukemia ◽  
Kinase Inhibitor ◽  
Cytogenetic Response ◽  
Inhibitor Therapy ◽  
Newly Diagnosed ◽  
Molecular Cytogenetic ◽  
Tyrosine Kinase Inhibitor Therapy

scholarly journals Skeletal muscle toxicity associated with tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia

Leukemia ◽  
2019 ◽  
Vol 33 (8) ◽  
pp. 2116-2120 ◽  
Author(s):  
L. Janssen ◽  
S. J. C. M. Frambach ◽  
N. A. E. Allard ◽  
M. T. E. Hopman ◽  
T. J. J. Schirris ◽  
...  
Keyword(s):  
Skeletal Muscle ◽  
Chronic Myeloid Leukemia ◽  
Tyrosine Kinase ◽  
Tyrosine Kinase Inhibitor ◽  
Myeloid Leukemia ◽  
Kinase Inhibitor ◽  
Inhibitor Therapy ◽  
Tyrosine Kinase Inhibitor Therapy ◽  
Muscle Toxicity
Sign in / Sign up

Export Citation Format

Share Document